Coexistent asthma and/or allergic rhinitis diagnosis and prescribed medication among patients examined 2 years before and 2 years after the initial SCD-pulmonary clinic visit
| Characteristic . | Before . | After . | P values . |
|---|---|---|---|
| Diagnoses | |||
| Asthma | 75 (64) | 88 (75) | .0123 |
| Allergic rhinitis | 27 (23) | 43 (36) | .0124 |
| Medications | |||
| Hydroxyurea | 62 (52) | 77 (65) | .0051 |
| ICS | 50 (42) | 68 (57) | .0046 |
| ICS/LABA∗ | 14 (12) | 18 (15) | .34 |
| Characteristic . | Before . | After . | P values . |
|---|---|---|---|
| Diagnoses | |||
| Asthma | 75 (64) | 88 (75) | .0123 |
| Allergic rhinitis | 27 (23) | 43 (36) | .0124 |
| Medications | |||
| Hydroxyurea | 62 (52) | 77 (65) | .0051 |
| ICS | 50 (42) | 68 (57) | .0046 |
| ICS/LABA∗ | 14 (12) | 18 (15) | .34 |
Values shown as frequency (percentage).
ICS/LABA: combined inhaled corticosteroid + long-acting beta agonist.